Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Neoplasms
×
durvalumab
×
30 days
×
Clear all
Filters
3
NCT06031233
2026-03-30
MINUTE
Isala
Phase 4
Recruiting
776 enrolled
NCT05063565
2026-03-27
ROWAN
Boston Scientific Corporation
Phase 2
Active not recruiting
100 enrolled
NCT05303532
2026-03-24
ROSY-D
AstraZeneca
Phase 3
Enrolling by invitation
214 enrolled